Proto Script Pharmaceutical

Proto Script Pharmaceutical Rule of 40

The Rule of 40 of Proto Script Pharmaceutical (PSCR) as of Oct 13, 2026 is -23.66 %.

Rule of 40

-23.66 %

Last updated:

Rule of 40 of Proto Script Pharmaceutical is 2015 -23.66 % . Rule of 40 of Proto Script Pharmaceutical was 2014 - . It decreases by % lower compared to the previous year.

The Proto Script Pharmaceutical Rule of 40 history

The Proto Script Pharmaceutical Rule of 40 history
YEARRule of 40YoY
-23.66 %—
Access this data via the Eulerpool API

Proto Script Pharmaceutical Stock analysis

What does Proto Script Pharmaceutical do? Proto Script Pharmaceutical Corp is an American biotechnology company specializing in the development and manufacture of innovative, high-quality drugs. The company is focused on researching new breakthrough technologies in drug manufacturing to find potential cures and treat diseases. Their business model is based on producing medications that are highly effective and of high quality while also being cost-effective and patient-friendly. They collaborate closely with biotechnology companies and academic institutions to acquire the best technologies and develop effective and innovative drugs. They have products in the areas of neurology, endocrine health, and oncology. They have also entered into partnerships with other companies to expand and further develop their products. Overall, Proto Script Pharmaceutical Corp is a groundbreaking company in the biotechnology field with decades of experience in drug development and a commitment to improving the lives of millions of people worldwide. Proto Script Pharmaceutical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Proto Script Pharmaceutical stock

Rule of 40 of Proto Script Pharmaceutical is -23.66 % in 2015.

On Eulerpool you can find the complete historical development of Rule of 40 Proto Script Pharmaceutical since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

Quality — Proto Script Pharmaceutical

All Key Metrics — Proto Script Pharmaceutical